€∏;The 12th Internatio→>nal Symposium on DNA γ Damage Response &¶α£ Human Disease(isDDRHD-202‍λ≈1) was held at the C↓≠εγenter for Excellence in Molecular $±₽€Cell Science, Chinese Academy of S÷ ↓ ciences on October 22-24, 2 ♣021. isDDRHD was initiated by Pr∏©of. Xu Xingzhi and Academician Zhao-Qi ♠'↓Wang in 2010 to provide a platform §'for communication between Ch≤€✔€inese scholars and interλ$λβnational mainstream labo®↕ratories in the field of DNA≤‍©​ repair. Since then, the ann↕γ$φual conference has becom↑'∑φe an international ac§Ωademic event, attracting many♣©✔☆ international academic masters. As δ¶σa regular participant of th✔γe conference, SynRx Therapeutics team§≤→↑ addressed the topic p₽→resentation as a keyβ¶₩•note speaker and host of this sympo∞₽←sium. In this symposium, P₩≠©$rof. Yu Xiaochun served as a member of &Ωthe academic committee.